MYRTLE SANDERS: Open Payments
NPI 1487648648 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,636 in 162 payments from 18 companies in 2025. Trend: 2023 $2,423 · 2024 $2,661 · 2025 $3,636
Food & beverage: $3,551Education: $85
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 19 | $721 |
| ABBVIE INC. | 33 | $602 |
| UCB, Inc. | 18 | $290 |
| Janssen Biotech, Inc. | 11 | $276 |
| Novartis Pharmaceuticals Corporation | 12 | $262 |
| Arcutis Biotherapeutics, Inc. | 4 | $238 |
| Incyte Corporation | 9 | $195 |
| GENZYME CORPORATION | 8 | $185 |
| E.R. Squibb & Sons, L.L.C. | 12 | $165 |
| Lilly USA, LLC | 8 | $158 |
Products named: DUPIXENT, SKYRIZI, Bimzelx, TREMFYA, Zoryve, RINVOQ, OPZELURA, COSENTYX.
Industry payments across GA — which companies pay providers there.
